Moderna Affirms FY2026 Sales Guidance of $2.138B vs $2.089B Est

Benzinga Newsdesk www.benzinga.com Positive 56.9%

Neg 0% Neu 0% Pos 56.9%

Moderna (NASDAQ:MRNA) affirms FY2026 sales outlook from $2.138 billion to $2.138 billion vs $2.089 billion estimate.

Comments

No comments yet. Be the first!